4.7 Article

Umbilical cord mesenchymal stromal cells in serum-free defined medium display an improved safety profile

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biotechnology & Applied Microbiology

Physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell-based therapy products

Dominik Egger et al.

Summary: The utilization of mesenchymal stem/stromal cells in treating diseases and pathological conditions brings new hopes and challenges for researchers, manufacturers, and physicians. Optimal protocols for isolation, cultivation, and differentiation of these cells are essential for efficient and reproducible treatment outcomes. Physiological in vitro cell cultivation conditions, such as three-dimensional culture and relevant oxygen concentrations, play a crucial role in enhancing therapeutic functionalities of cultivated cells in regenerative medicine.

ENGINEERING IN LIFE SCIENCES (2022)

Article Ophthalmology

Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats

Qingling Liang et al.

Summary: The intravenous infusion of small umbilical cord mesenchymal stem cells (S-UCMSCs) is found to be safer and more effective for the treatment of retinitis pigmentosa (RP) compared to traditional UCMSCs. It can delay retinal degeneration and protect visual function.

BMC OPHTHALMOLOGY (2022)

Article Cell & Tissue Engineering

Optimization of human umbilical cord blood-derived mesenchymal stem cell isolation and culture methods in serum- and xeno-free conditions

Liem Thanh Nguyen et al.

Summary: This study evaluated the efficiency of UCB-MSC isolation and expansion using different commercially available media kits and found that StemMACS(TM) MSC Expansion Media is more appropriate. Autologous serum coating and plasma supplement enhanced cell proliferation. UCB-MSCs exhibited functions in promoting angiogenesis and inhibiting cancer cell growth.

STEM CELL RESEARCH & THERAPY (2022)

Review Cell Biology

Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization

Mehdi Najar et al.

Summary: Cellular therapy aims to replace damaged cells and restore the cellular and molecular environments for tissue repair. Mesenchymal stem/stromal cells (MSCs) have therapeutic potential in various diseases. However, the origin and function of MSCs are still debated. The therapeutic properties of MSCs are influenced by their environment, including culture conditions and immunobiology.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Cell Biology

Adipose-Derived Stem Cells From Patients With Ulcerative Colitis Exhibit Impaired Immunosuppressive Function

Xiaoyun Wu et al.

Summary: The study revealed that ADSCs from UC patients exhibited defective immunosuppression, indicating their unsuitability for autologous transplantation in treating UC.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Cell & Tissue Engineering

Pancreatic cancer growth promoted by bone marrow mesenchymal stromal cell-derived IL-6 is reversed predominantly by IL-6 blockade

Roula Antoon et al.

Summary: Pancreatic cancer is a highly lethal cancer characterized by invasiveness, metastasis, recurrence, and resistance to therapy. This study found that bone marrow mesenchymal stromal cells (MSCs) significantly contribute to pancreatic cancer growth by creating a pro-carcinogenic microenvironment through the release of key factors and activation of signaling pathways. IL-6 released by MSCs plays a pivotal role in promoting tumor growth. Blockade of IL-6 or its downstream effector STAT3 can effectively inhibit MSC-mediated tumor promotion.

CYTOTHERAPY (2022)

Article Reproductive Biology

Toxicity from a single injection of human umbilical cord mesenchymal stem cells into rat ovaries

Libing Shi et al.

Summary: This study evaluated the toxic effects and affected target organs after the intraovarian injection of human umbilical cord mesenchymal stem cells (hUC-MSCs) in rats. The high-dose group had a significantly higher mortality rate compared to the control and low-dose groups, and the ovary and oviduct may be the target organs for this toxicity.

REPRODUCTIVE TOXICOLOGY (2022)

Article Cell & Tissue Engineering

Standard toxicity study of clinical-grade allogeneic human bone marrow-derived clonal mesenchymal stromal cells

Behnoosh Tayebi et al.

Summary: Mesenchymal stromal cells (MSCs) have shown potential in treating inflammatory and non-inflammatory diseases, but their clinical applications require strict evaluations and monitoring to ensure compliance with safety standards. This study aimed to assess the potential toxicity effects of cryopreserved human bone marrow-derived clonal MSCs in animal models during different time periods.

STEM CELL RESEARCH & THERAPY (2022)

Article Cell Biology

Reproductive and Developmental Toxicity Assessment of Human Umbilical Cord Mesenchymal Stem Cells in Rats

Xiaobo Li et al.

Summary: The study evaluated the effects of intravenous injection of hUC-MSCs on reproduction and development in rats, finding no significant adverse effects within a certain dosage range, but high doses may lead to mortality in pregnant female rats, highlighting the importance of cautious use.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Cell Biology

Mesenchymal/stromal stem cells: necessary factors in tumour progression

Xinyu Li et al.

Summary: MSCs in the tumour microenvironment play a crucial role in promoting tumour development. Utilizing exosomes as communicators offers potential for improving outcomes and developing targeted treatment.

CELL DEATH DISCOVERY (2022)

Review Oncology

Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance

Xiuyun Xuan et al.

Summary: The tumor microenvironment plays a crucial role in cancer progression and therapeutic resistance, with MSCs being a distinct type of cells linked to tumor development. MSCs can both promote and inhibit cancer cell proliferation and metastasis, as well as contribute to therapeutic resistance.

CANCER CELL INTERNATIONAL (2021)

Review Oncology

Mesenchymal stem/stromal cells in cancer therapy

Tianxia Lan et al.

Summary: Multipotent mesenchymal stem/stromal cells (MSCs) have been identified in almost all tissues of the human body, showing potential in cancer treatment due to their multipotency, immunomodulation capacity, and tumor-homing property. However, controversial roles of MSCs in crosstalk with tumors hinder translational medicine progress.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Oncology

Preclinical Safety Evaluation of Intranasally Delivered Human Mesenchymal Stem Cells in Juvenile Mice

Yolanda Aguilera et al.

Summary: Utilizing mesenchymal stem cells through intranasal application is a safe and non-invasive strategy for treating neurological disorders, as evidenced by studies conducted on mice. The repeated doses of cells administered through the nostrils did not cause any serious adverse events or tumor formation, demonstrating the potential for future clinical trials. These findings support the use of intranasal MSC therapy for managing central nervous system diseases.

CANCERS (2021)

Review Cell & Tissue Engineering

Developing standards to support the clinical translation of stem cells

Jiani Cao et al.

Summary: Stem cells have great potential for regenerative medicine, but clinical translation remains challenging. Establishing a set of standards is crucial for supporting the clinical translation of stem cell applications.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Review Cell & Tissue Engineering

Development and investigational new drug application of mesenchymal stem/stromal cells products in China

Qinjun Zhao et al.

Summary: The regulations for clinical application of MSCs therapy in China have been updated in recent years, with increasing efforts from biotech companies in developing MSC products. Discussions and research on MSC regulation have become hot topics in professional journals.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Review Cell & Tissue Engineering

Biodistribution studies for cell therapy products: Current status and issues

Yoshiteru Kamiyama et al.

Summary: Information on the biodistribution of cell therapy products is crucial for predicting and assessing their efficacy and toxicity. Understanding regulatory requirements, implementation status, and analytical methods is necessary for conducting BD studies. The results of this review will serve as a useful resource for implementing BD studies.

REGENERATIVE THERAPY (2021)

Article Cell Biology

Mesenchymal Stem Cells With Cancer-Associated Fibroblast-Like Phenotype Stimulate SDF-1/CXCR4 Axis to Enhance the Growth and Invasion of B-Cell Acute Lymphoblastic Leukemia Cells Through Cell-to-Cell Communication

Chengyun Pan et al.

Summary: BM-MSCs with CAF-like phenotype may play a key role in promoting the growth and invasion of B-ALL cells, and the SDF-1/CXCR4 axis could be a significant factor in mediating the communication between MSCs with CAF-like phenotype and leukemia cells. Blocking the SDF-1/CXCR4 axis with AMD3100 or targeting integrin beta 1 may serve as a potential therapeutic strategy to prevent the progression of B-ALL cells.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Multidisciplinary Sciences

Performance of preclinical models in predicting drug-induced liver injury in humans: a systematic review

Hubert Dirven et al.

Summary: Despite the lack of accurate prediction of troglitazone's potential to cause severe liver injury based on animal and human trials, both in vitro and in vivo studies showed marked differences in off-target effects between the two drugs. Troglitazone exhibited higher activity in in vitro assays and substantially higher rates of DILI-related adverse events and fatalities compared to rosiglitazone, suggesting a new paradigm for reducing drug attrition in late development and in the market.

SCIENTIFIC REPORTS (2021)

Review Cell Biology

Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications

Wei-Zhan Zhuang et al.

Summary: Mesenchymal stem/stromal cells (MSCs) are a promising resource for cell-based therapy due to their high immunomodulation ability and tropism towards inflamed and injured tissues. However, the lack of standardized methods to evaluate the safety, efficacy, and biodistribution of MSCs has been a major hindrance to their clinical application.

JOURNAL OF BIOMEDICAL SCIENCE (2021)

Article Cell & Tissue Engineering

Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range?

Maciej Kabat et al.

STEM CELLS TRANSLATIONAL MEDICINE (2020)

Article Biotechnology & Applied Microbiology

Serum-Free Medium Enhances the Therapeutic Effects of Umbilical Cord Mesenchymal Stromal Cells on a Murine Model for Acute Colitis

Xiaoyun Wu et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Article Cell & Tissue Engineering

Banking Mesenchymal Stromal Cells from Umbilical Cord Tissue: Large Sample Size Analysis Reveals Consistency Between Donors

Vanessa N. Raileanu et al.

STEM CELLS TRANSLATIONAL MEDICINE (2019)

Article Cell & Tissue Engineering

Evaluation of different routes of administration and biodistribution of human amnion epithelial cells in mice

Raghuraman C. Srinivasan et al.

CYTOTHERAPY (2019)

Review Cell & Tissue Engineering

Concise Review: Quantitative Detection and Modeling the In Vivo Kinetics of Therapeutic Mesenchymal Stem/Stromal Cells

Anastasia Brooks et al.

STEM CELLS TRANSLATIONAL MEDICINE (2018)

Article Medicine, Research & Experimental

Fetal Bovine Serum (FBS): Past - Present - Future

Jan van der Valk et al.

ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2018)

Review Cell & Tissue Engineering

Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events

Navid Mohamadpour Toyserkani et al.

STEM CELLS TRANSLATIONAL MEDICINE (2017)

Article Cell & Tissue Engineering

Current perspectives on the use of ancillary materials for the manufacture of cellular therapies

Jennifer Solomon et al.

CYTOTHERAPY (2016)

Review Cell & Tissue Engineering

Role of Stromal-Derived Factor-1 in Mesenchymal Stem Cell Paracrine-mediated Tissue Repair

Qing Luo et al.

CURRENT STEM CELL RESEARCH & THERAPY (2016)

Article Cell & Tissue Engineering

Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses

Sean D. Owens et al.

STEM CELLS INTERNATIONAL (2016)

Article Multidisciplinary Sciences

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

EM Horwitz et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)